Subsequently, we investigated the TUBA1B influence on patients’ PFS to investigate the possible connection between TUBA1B and the growth of tumors in patients; it was found that TUBA1B affected the PFS of the following patients: ACC (p = 0.002, HR = 2.86), BLCA (p = 0.022, HR = 1.42), ESAD (p = 0.013, HR = 2.24), LGG (p = 0.010, HR = 1.44), LIHC (p = 0.001, HR = 1.63), LUAD (p = 0.003, HR = 1.51), MESO (p = 0.002, HR = 2.37), and SARC (p = 0.005, HR = 1.61) (Figs. 4C; S3C). The gene discussed is TUBA1B; the disease is adrenal cortex carcinoma.